Study of tumor markers for lymph node spread in gastric cancer
Part of Cancer clinical trials.
This study looks at how certain markers in your stomach cancer tumor might predict whether cancer has spread to nearby lymph nodes. It could help doctors decide if you need more treatment after surgery or if a less invasive procedure is enough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had surgery to remove your stomach cancer, and the cancer was confirmed as adenocarcinoma (the most common type of stomach cancer).
- You did not receive chemotherapy, radiation, or other cancer treatments before your surgery.
- Your surgery was done at Zhongshan Hospital in Shanghai.
- Your tumor was in a specific part of the stomach or where the stomach meets the esophagus (types II and III).
- Your doctors have complete information about your tumor, including whether it invaded lymph vessels and whether lymph nodes were affected, and your MMR status (a genetic marker) is known.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how stomach cancer spreads to lymph nodes and other tissues behind the stomach during surgery. It may help doctors understand which patients need more extensive surgery.
This trial studies the importance of checking lymph nodes in the fatty tissue around the stomach during stomach cancer surgery. It helps doctors understand if examining these specific areas can improve treatment decisions.
This study looks at where cancer spreads in the short stomach area after total stomach removal surgery. It aims to understand lymph node and tumor deposits better to help guide future treatment decisions.
This study looks at how esophageal (or esophagus-stomach junction) cancer spreads to nearby lymph nodes. Results may help doctors understand where cancer cells are likely to be, potentially improving future surgery planning.
This trial tests a new image-guided method to find and remove sentinel lymph nodes (the first nodes where cancer might spread) in people with early stomach cancer. The goal is to precisely remove only the affected lymph nodes during surgery, which might mean a less extensive operation and fewer side effects.
This study tests if artificial intelligence can predict whether early-stage stomach cancer has spread to lymph nodes. It also evaluates how well doctors assess the cancer. If the technology works, it could help guide treatment decisions.
Hear when a new Gastric / Gastroesophageal Junction Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.